Each year in this country approximately 180,000 women are diagnosed as having breast cancer, a terrible disease that will claim nearly 50,000 lives. But, nearly 2.6 million women are breast cancer survivors, in part because of the availability of Tamoxifen citrate, a widely used post-operative drug for this disease. My colleagues may not be aware that a low-cost version of Tamoxifen is available on the market today. As a result, the estimated 800,000 women who take two tablets per day of this lower cost medicine are saving a total of $81 million a year. It has not been widely publicized, but during consideration of the Balanced Budget Act, a provision was included in the now-vetoed conference report to amend the Medicare Program to include reimbursement for Tamoxifen. Unfortunately, I believe my colleagues were unaware of the negative effects of this rebate provision when it was passed as part of the budget bill.
Orrin Hatch: “Each year in this country approximately 180,000 women are diagnosed as having breast cancer, a terrible disease that…”
On the recordJanuary 26, 1996
Source
govinfo.govEditor's note · Context
Discussing breast cancer treatment and Medicare reimbursement for Tamoxifen during a floor speech.
Share
More from Orrin Hatch
Sep 18, 2018
for more than four decades, I have had the distinct privilege of serving in the U.S. Senate, what some have called the world's greatest deliberative body. Speaking on the Senate floor, debating legislation in committee, corralling the…
Dec 19, 2018
what can you say about a dear friend who has passed away? That he was brilliant? And supremely accomplished? That he loved family and church? And the law? And people from all walks of life? To say these things does not nearly capture the…
Sep 25, 2018
Our trade policy should strengthen our relationships with our allies while targeting China's most harmful trade practices.





